134 related articles for article (PubMed ID: 7067661)
21. Neurophysiological markers of relapse, remission and long-term recovery processes in MS.
Jones SJ; Brusa A
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():584-90. PubMed ID: 10689512
[No Abstract] [Full Text] [Related]
22. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
[TBL] [Abstract][Full Text] [Related]
23. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
[TBL] [Abstract][Full Text] [Related]
24. Recovery after optic neuritis in childhood.
Kriss A; Francis DA; Cuendet F; Halliday AM; Taylor DS; Wilson J; Keast-Butler J; Batchelor JR; McDonald WI
J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1253-8. PubMed ID: 3225583
[TBL] [Abstract][Full Text] [Related]
25. [Binocular photometer for measuring light perception in diseases of the visual pathway].
Stave J; Guthoff R
Ophthalmologe; 1995 Apr; 92(2):191-4. PubMed ID: 7780279
[TBL] [Abstract][Full Text] [Related]
26. Presumed bilateral optic nerve sheath meningiomas presenting as optic neuritis.
Sawaya RA; Sidani C; Farah N; Hourani-Risk R
J Neuroophthalmol; 2008 Mar; 28(1):55-7. PubMed ID: 18347461
[TBL] [Abstract][Full Text] [Related]
27. Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.
Jenkins T; Ciccarelli O; Toosy A; Miszkiel K; Wheeler-Kingshott C; Altmann D; Mancini L; Jones S; Plant G; Miller D; Thompson A
Hum Brain Mapp; 2010 Feb; 31(2):276-86. PubMed ID: 19662659
[TBL] [Abstract][Full Text] [Related]
28. Normal and abnormal fMRI activation patterns in the visual cortex after recovery from optic neuritis.
Levin N; Orlov T; Dotan S; Zohary E
Neuroimage; 2006 Dec; 33(4):1161-8. PubMed ID: 17011793
[TBL] [Abstract][Full Text] [Related]
29. [Follow-up of patients with acute optic nerve neuritis].
Berninger T; Heider W
Fortschr Ophthalmol; 1985; 82(6):595-600. PubMed ID: 4093111
[No Abstract] [Full Text] [Related]
30. Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
Klistorner A; Graham S; Fraser C; Garrick R; Nguyen T; Paine M; O'Day J; Grigg J; Arvind H; Billson FA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4549-56. PubMed ID: 17898277
[TBL] [Abstract][Full Text] [Related]
31. Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis.
Leocani L; Guerrieri S; Comi G
J Neuroophthalmol; 2018 Sep; 38(3):350-357. PubMed ID: 30106802
[TBL] [Abstract][Full Text] [Related]
32. [Latency time in pattern-evoked ERG and VECP in patients with optic nerve diseases].
Teping C; Groneberg A; Lapp ER
Fortschr Ophthalmol; 1982; 79(4):361-3. PubMed ID: 7185714
[No Abstract] [Full Text] [Related]
33. The value of neurophysiological and MRI assessment in demyelinating optic neuritis (DON).
Fotiou F; Koutlas E; Tsorlinis I; Dimitriades A; Fountoulakis K; Tsiptsios I; Sitzoglou K; Karampatakis V; Stangos N
Electromyogr Clin Neurophysiol; 1999; 39(7):397-404. PubMed ID: 10546075
[TBL] [Abstract][Full Text] [Related]
34. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
Frohman EM; Costello F; Stüve O; Calabresi P; Miller DH; Hickman SJ; Sergott R; Conger A; Salter A; Krumwiede KH; Frohman TC; Balcer L; Zivadinov R
Arch Neurol; 2008 Jan; 65(1):26-35. PubMed ID: 18195137
[TBL] [Abstract][Full Text] [Related]
35. Optic neuritis: swelling and atrophy.
Youl BD; Turano G; Towell AD; Barrett G; MacManus DG; Moore SG; Miller DH; Jones SJ; du Boulay EP; Kendall BE; Moseley IF; McDonald WI
Electroencephalogr Clin Neurophysiol Suppl; 1996; 46():173-9. PubMed ID: 9059791
[No Abstract] [Full Text] [Related]
36. [Treatment of acute optic neuritis with high dose of prednisone].
Liu Q; Zhang M; Ai F; Jiang R; Hu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):230-5. PubMed ID: 11367712
[TBL] [Abstract][Full Text] [Related]
37. Follow-up studies on pattern reversal visually evoked cortical potentials in a 2-year-old child with optic neuritis.
Sato K; Adachi-Usami E; Mizota A
J Neuroophthalmol; 1998 Mar; 18(1):21-4. PubMed ID: 9532534
[TBL] [Abstract][Full Text] [Related]
38. V.E.R. and subclinical optic pathway damage.
Neetens A; Hendrata Y; Van Rompaey J; Rubbens MC; Verschueren C
Bull Soc Belge Ophtalmol; 1979; 185():83-98. PubMed ID: 540195
[No Abstract] [Full Text] [Related]
39. Axonal loss in a rat model of optic neuritis is closely correlated with visual evoked potential amplitudes using electroencephalogram-based scaling.
You Y; Klistorner A; Thie J; Gupta VK; Graham SL
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3662. PubMed ID: 22723598
[No Abstract] [Full Text] [Related]
40. [Visual evoked potentials in optic nerve diseases].
Rouher F; Plane C; Solé P
Arch Ophtalmol Rev Gen Ophtalmol; 1969; 29(6):555-64. PubMed ID: 4242357
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
